The NEXTUBIN brand, founded in 2007 (United States), from 496 sister brands and 17478 competing brands. The NEXTUBIN brand is owned by BRISTOL-MYERS SQUIBB COMPANY, a company listed in New York. NEXTUBIN belongs to the Drug Manufacturers business sector.